Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,445 | -9,689 | -6,939 | -4,320 | -5,364 |
| Depreciation Amortization | 208 | 79 | 26 | 43 | 602 |
| Accounts payable and accrued liabilities | -431 | 198 | 532 | -195 | -128 |
| Other Working Capital | 104 | -443 | 1,342 | -107 | -521 |
| Other Operating Activity | 1,030 | 449 | -249 | 501 | -1,548 |
| Operating Cash Flow | $-10,534 | $-9,406 | $-5,288 | $-4,078 | $-6,959 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -19 | -32 | N/A | 6 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 2,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 2,000 |
| Investing Cash Flow | $-11 | $-19 | $-32 | $N/A | $2,006 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 37,000 | 9,038 | 1,741 | 1,528 | 4,726 |
| Other Financing Activity | -3,007 | -1,015 | 17,415 | -473 | -855 |
| Financing Cash Flow | $33,993 | $8,023 | $19,156 | $1,055 | $3,871 |
| Beginning Cash Position | 15,354 | 16,756 | 2,920 | 5,943 | 7,025 |
| End Cash Position | 38,802 | 15,354 | 16,756 | 2,920 | 5,943 |
| Net Cash Flow | $23,448 | $-1,402 | $13,836 | $-3,023 | $-1,082 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,534 | -9,406 | -5,288 | -4,078 | -6,959 |
| Capital Expenditure | -11 | -19 | -32 | N/A | -19 |
| Free Cash Flow | -10,545 | -9,425 | -5,320 | -4,078 | -6,978 |